January 3, 2023
Meet Maggie!
Maggie El Naamani returned to FirstXFounder as a full-time team member in February 2023, having previously acted as a consultant for the organization from 2018-2020. She is the Senior Program Coordinator of the ABCT program, leading operations and event coordination for the CT based accelerator program. Maggie began her career in higher education where she served in various roles, concluding as the Associate Director of International Admissions at Sacred Heart University. Her academic background is in business and anthropology and she has a special interest in cultural competency in the workplace.
Ask Maggie about exciting events happening in Connecticut at maggie@firstxfounder.com!
Mark Your Calendar
BIOCT LEGISLATIVE BREAKFAST
Jan. 22, 2024: 8:00AM-10:00AM, 100 College St., New Haven, CT
ELABNYC PANEL: BUSINESS INCENTIVES FOR SMALL COMPANIES
Jan. 31, 2024 8:00AM-10:30AM - 360 Hamilton Ave, White Plains, NY
congratulations
Alexey Melnik, Arome
Diagnostic | Autoimmune, Inflammation
Entered into a research and development partnership agreement with Thorne HealthTech
Neetika Ashwani, KRIASH
Medical Device | Healthcare Management
Won first place in the Career Design Lab - Columbia University Greater Good Challenge 2023
Joe Landolina, Cresilon
Medical Device | Biomaterials
Joined New York City Mayor Eric Adams as he signed renewed biotech tax credit bill
Linh Lee, Piezobiomembrane
Therapeutic | Regenerative Medecine
Accepted at Uconn TIP
Justine Witzke, Aligneage Fertility
Healthcare Delivery | Women's Health
Clinic licensed by the New York State Department of Health and registered with FDA
"Say hello to the
2024 Cohorts!"
Bobbianne Elizabeth, Tenacity Art
Independent
Tenacity Art, developed the VR/EMDR app, offering immersive 3D therapy to patients. For clinicians, it includes a real-time trauma treatment database and a machine learning BE.Well algorithm for home-based mental health treatment.
Courtney Rowe, M.D., Kelly Burke, Ph.D., Christopher Foster, Pain Relief Film
CT Children's
Biodegradable implantable pain film to deliver targeted, sustained, opioid-free local anesthetics for postoperative pain control.
Joseph Gennaro, Ph.D, Exoscope
Yale
Exoscope is developing a liquid biopsy-based diagnostic to enable precision treatment of acute rejection in heart transplant patients.
Joshua Gilmore, Social Health Passport
Independent
Social Health Passport (SHP) is an end users and social service providers platform to share information and resources to support their client’s social mobility and self-sufficiency
Julien Berro, Ph.D. & Yuan Ren, Ph.D.
Yale
Biosensors for Force-Based Diagnostics and Therapeutics.
Ming Hui, Mobabbi
Independent
First complete potty training solution that teaches babies to use the potty at an earlier age using sound association.
Mustafa Khokha, M.D., Victory Genomics
Yale
Victory Genomics uses the latest in genomics technologies to advance horse health, welfare, and performance.
Ons M'Saad, Ph.D., Panluminate
Yale
Panluminate is developing pan-OptiX, a tissue analytics platform which allows scientists to identify new disease biomarkers and catalog the cellular signatures underlying fundamental drug interactions.
Prisca Obi, Virtus Therapeutics
Yale
Virtus Therapeutics is actively developing a new class of small-molecule activators for treatment of propionic acidemia, a rare metabolic disease.
Vanessa Sena & Helen Wu, My Local Chef
Indepedent
Our personalized nutrition program integrates the expertise of dietitians and the culinary artistry of our chefs. We individualize patient care through tailored Medical Nutrition Therapy.
Anita Lee, Digital Twin for Humans
Independent
Digital Twin for Humans uses conversational and generative AI to assess, identify, and address health and social service needs throughout a person’s lifetime.
Ariel Yusupov
Independent
Our gene therapy, currently focused on prostate cancer, utilizes over-expressing factors in cancer to drive a multi-modal attack, designed to prevent resistance and more aggressive disease.
Daniel Gareau, SurgiVance
Rockefeller
SurgiVance is advanced surgical pathology to drive better cancer care. Our objective is to solidify the business development plan for our product in pathology markets including specialty surgery.
Evris Gavathiotis
Einstein
Our technology encompasses a novel small molecule therapeutic strategy that exhibits broad efficacy in diverse cancers, aiming to advance to clinical stage.
Glen Prusky, Gaze Engine
Weill Cornell
An efficient methodology to measure the visual contrast sensitivity function, which promises to replace visual acuity measures as the standard for routine vision assessment.
Hourinaz Behesti,
Hebbian Bio
Rockefeller
Hebbian Bio is building a personalized technology platform to develop first-in-class therapeutics for patients with currently untreatable neurodevelopmental/psychiatric disorders.
Illia Popov, ComeBack Mobility
Independent
ComeBack Mobility has developed a Smart Crutch Tips IoT device & mob apps that let patients know how to apply the right amount of force to the recovering limb + remote therapeutic monitoring service for providers. It reduces the number of revision surgeries, expediting recovery for 8 weeks & improving healing with additional revenue for practices.
Katia Rojas, Suabix
Independent
Suabix is a groundbreaking startup that seamlessly integrates the fit-for-purpose maturity framework Successful Human Factors 2.0, with cutting-edge AI technology. It empowers healthcare product development with needed guidance for the optimization of human factors/usability projects.
Kirsten Hund Blair & Kevin McClarren, Lambent
Independent
Lambent’s software equips healthcare/social service providers and empowers patients/clients, to improve outcomes in health and Social Drivers of Health and reduce healthcare costs.
Michael Beaton
Independent
A mobile app that can provide contact tracing for sexually transmitted infections using blockchain technology. Using Lateral Flow Assays to 'token gate' communities and issue NFT badges as a certificate of health to be displayed on online dating sites.
Robin Ji & Elisa Konofagou, Delsona Therapeutics
Columbia
A portable focused ultrasound system for non-invasive and targeted treatment of neurological diseases.
Zach Sawaged, Concordare
Independent
Concordare is a suite of web-application tools that have an exclusive ability to read and write a novel digital clinical trial protocol called a CPTM.
WCBA impact
abct impact
Want to tell us about your latest news?
Connect with us.